BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 33924766)

  • 1. Targeting RIP Kinases in Chronic Inflammatory Disease.
    Speir M; Djajawi TM; Conos SA; Tye H; Lawlor KE
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33924766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIP-roaring inflammation: RIPK1 and RIPK3 driven NLRP3 inflammasome activation and autoinflammatory disease.
    Speir M; Lawlor KE
    Semin Cell Dev Biol; 2021 Jan; 109():114-124. PubMed ID: 32771377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RIPK1 and RIPK3: critical regulators of inflammation and cell death.
    Newton K
    Trends Cell Biol; 2015 Jun; 25(6):347-53. PubMed ID: 25662614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necroptosis-independent signaling by the RIP kinases in inflammation.
    Moriwaki K; Chan FK
    Cell Mol Life Sci; 2016 Jun; 73(11-12):2325-34. PubMed ID: 27048814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.
    Lawlor KE; Khan N; Mildenhall A; Gerlic M; Croker BA; D'Cruz AA; Hall C; Kaur Spall S; Anderton H; Masters SL; Rashidi M; Wicks IP; Alexander WS; Mitsuuchi Y; Benetatos CA; Condon SM; Wong WW; Silke J; Vaux DL; Vince JE
    Nat Commun; 2015 Feb; 6():6282. PubMed ID: 25693118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diverse role of RIP kinases in necroptosis and inflammation.
    Silke J; Rickard JA; Gerlic M
    Nat Immunol; 2015 Jul; 16(7):689-97. PubMed ID: 26086143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial cells.
    Negroni A; Colantoni E; Pierdomenico M; Palone F; Costanzo M; Oliva S; Tiberti A; Cucchiara S; Stronati L
    Dig Liver Dis; 2017 Nov; 49(11):1201-1210. PubMed ID: 28844856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD.
    Chen H; Fang Y; Wu J; Chen H; Zou Z; Zhang X; Shao J; Xu Y
    Cell Death Dis; 2018 Aug; 9(9):878. PubMed ID: 30158627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation.
    Malireddi RKS; Gurung P; Mavuluri J; Dasari TK; Klco JM; Chi H; Kanneganti TD
    J Exp Med; 2018 Apr; 215(4):1023-1034. PubMed ID: 29500178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pathogenesis of Necroptosis-Dependent Signaling Pathway in Cerebral Ischemic Disease.
    Xu Y; Zhang J; Ma L; Zhao S; Li S; Huang T; Chu Z
    Behav Neurol; 2018; 2018():6814393. PubMed ID: 30140326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Wang Z; Feng J; Yu J; Chen G
    J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense.
    Zheng M; Karki R; Vogel P; Kanneganti TD
    Cell; 2020 Apr; 181(3):674-687.e13. PubMed ID: 32298652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed necrosis in the cross talk of cell death and inflammation.
    Chan FK; Luz NF; Moriwaki K
    Annu Rev Immunol; 2015; 33():79-106. PubMed ID: 25493335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis).
    Sharma BR; Karki R; Rajesh Y; Kanneganti TD
    J Biol Chem; 2023 Sep; 299(9):105141. PubMed ID: 37557956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection.
    Zheng M; Williams EP; Malireddi RKS; Karki R; Banoth B; Burton A; Webby R; Channappanavar R; Jonsson CB; Kanneganti TD
    J Biol Chem; 2020 Oct; 295(41):14040-14052. PubMed ID: 32763970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo.
    Shutinoski B; Alturki NA; Rijal D; Bertin J; Gough PJ; Schlossmacher MG; Sad S
    Cell Death Differ; 2016 Oct; 23(10):1628-37. PubMed ID: 27258786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.
    Moriwaki K; Chan FK
    Int Rev Cell Mol Biol; 2017; 328():253-275. PubMed ID: 28069136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molecular Links between Cell Death and Inflammasome.
    Lee KH; Kang TB
    Cells; 2019 Sep; 8(9):. PubMed ID: 31509938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necroptosis in development, inflammation and disease.
    Weinlich R; Oberst A; Beere HM; Green DR
    Nat Rev Mol Cell Biol; 2017 Feb; 18(2):127-136. PubMed ID: 27999438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed necrosis and necroptosis signalling.
    Feoktistova M; Leverkus M
    FEBS J; 2015 Jan; 282(1):19-31. PubMed ID: 25327580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.